PIPELINE

Compounds Indications
  • Pre-clinical
  • Phase 1
  • Phase 2
  • Phase 3
Emixustat HCI Stargardt Disease
Emixustat HCI Proliferative Diabetic Retinopathy

Compounds

Emixustat HCI

Indications  
Stargardt Disease
  • Pre-clinical
  • Phase 1
  • Phase 2
  • Phase 3

Compounds

Emixustat HCI

Indications  
Proliferative Diabetic Retinopathy
  • Pre-clinical
  • Phase 1
  • Phase 2
  • Phase 3
Gene Therapy Indications
  • Pre-clinical
  • Phase 1
  • Phase 2
  • Phase 3
Human Rhodopsin Retinitis Pigmentosa

Gene Therapy

Human Rhodopsin

Indications  
Retinitis Pigmentosa
  • Pre-clinical
  • Phase 1
  • Phase 2
  • Phase 3
Device Description
  • Design &
    Prototype
  • Clinical Trial &
    Product Eng.
  • Regulatory
    Approval
Remote Retinal
Monitoring Device
Home-based miniature OCT
 (optical coherence tomography)
NASA High-Res Version SANS
Spaceflight Associated Neuro-ocular Syndrome

Device

Remote Retinal
Monitoring Device

Description  
Home-based miniature OCT
 (optical coherence tomography)
  • Design &
    Prototype
  • Clinical Trial &
    Product Eng.
  • Regulatory
    Approval
 

Device

NASA High-Res Version

Description  
SANS Spaceflight Associated Neuro-ocular Syndrome
  • Design &
    Prototype
  • Clinical Trial &
    Product Eng.
  • Regulatory
    Approval

Kubota Glasses - wearable device for myopia control

A clinical study with a prototype design of the smart glasses is scheduled to be completed in the latter half of 2020, and a wearable prototype is expected to be available by December 2020. Please see May 17, 2020 press release titled "Kubota Vision Introduces Electronic Eyeglasses to Stop Myopia in Children" for more details.

  • photo
  • photo
  • photo